About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows, ET HealthWorld
London: About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk’s weight-loss drug Wegovy, a study…